Xiaowei Chang
Director/Board Member at AMBRX INC
Profile
Xiaowei Chang is currently the Director at Ambrx, Inc. and the Managing Director-Healthcare Investment at Hopu Investments Co. Ltd.
He previously served as an Independent Director at Ambrx Biopharma Cayman, Inc. from 2015 to 2023 and as a Senior Associate at China International Capital Corp.
Ltd.
(Private Equity) from 2011 to 2014.
Mr. Chang received his undergraduate and graduate degrees from Tsinghua University.
Xiaowei Chang active positions
Companies | Position | Start |
---|---|---|
AMBRX INC | Director/Board Member | 31/05/2015 |
Hopu Investments Co. Ltd.
Hopu Investments Co. Ltd. Financial ConglomeratesFinance Hopu Investments Co. Ltd. functions as an investment holding Caymanian company. | Corporate Officer/Principal | 31/12/2013 |
Former positions of Xiaowei Chang
Companies | Position | End |
---|---|---|
Ambrx Biopharma, Inc.
Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | Director/Board Member | 05/10/2023 |
China International Capital Corp. Ltd. (Private Equity) | Corporate Officer/Principal | 31/12/2013 |
Training of Xiaowei Chang
Tsinghua University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 4 |
---|---|
Ambrx, Inc.
Ambrx, Inc. Pharmaceuticals: MajorHealth Technology Ambrx, Inc. engages in discovering and developing of protein therapeutics. It offers non-native amino acids through expanded genetic code to both generate novel bio-therapeutics. The company was founded by Richard DiMarchi, Peter G. Schultz, and Troy E. Wilson on April 15, 2003 and is headquartered in La Jolla, CA. | Health Technology |
Hopu Investments Co. Ltd.
Hopu Investments Co. Ltd. Financial ConglomeratesFinance Hopu Investments Co. Ltd. functions as an investment holding Caymanian company. | Finance |
China International Capital Corp. Ltd. (Private Equity) | Finance |
Ambrx Biopharma, Inc.
Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | Health Technology |
- Stock Market
- Insiders
- Xiaowei Chang